
Opinion|Videos|June 17, 2024
Epidemiology and Impact of Hidradenitis Suppurativa
Author(s)Iltefat Hamzavi, MD
An expert on hidradenitis suppurativa discusses the epidemiology of the disease and its profound impact on patients’ lives.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What are some of the important epidemiological figures that are associated with hidradenitis suppurativa (HS) and how can clinicians incorporate these into their practices?
- How can this disease negatively impact patients’ lives?
Advertisement
Related to this article

In a single-clinic study, 61.5% of patients with psoriasis screened positive for psoriatic arthritis using a validated questionnaire.

San Francisco experts say payer step edits and weak biologic follow-up slow atopic dermatitis care and point to pharmacy teams and dashboards.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First siRNA Therapy for AChR-Positive Myasthenia Gravis
2
Complicated UTI Care Strained by Unclear Goals, Access Gaps
3
Hepatitis B Screening Gaps Persist as Functional Cure Option Arrives
4
FDA Approves Oral Giredestrant Regimen for ESR1-Mutated Breast Cancer
5


